The Checkup by Singlecare

MARCH 31, 2024

Most people know the risks of driving under the influence of alcohol, but many are unaware of how certain medications can affect their driving abilities. Prescription side effects can cause drowsiness, vision changes, impaired motor skills, delayed reaction time, and even lack of focus—all of which are dangerous when operating a vehicle. Given the various ways medications can impair driving, it’s crucial to understand how the substances in your system may affect your ability to drive safel

Medication Labelling 105

Medication Labelling Labelling Communication Immunization 105

Pharmacy Times

MARCH 31, 2024

Interactions between nirmatrelvir/ritonavir and direct oral anticoagulants is complicated, and a point of contrasting views between the US and EU medical communities.

101

101

The Checkup by Singlecare

MARCH 31, 2024

Adderall contains a mixture of two central nervous system stimulants ( CNS ), amphetamine and dextroamphetamine. It is approved by the United States Food and Drug Administration (FDA) to treat symptoms of attention deficit hyperactivity disorder ( ADHD ) in adults and children 3 years and older. It can also be used to treat narcolepsy in adults and children 6 years and older.

Controlled Substances 102

Controlled Substances FDA 102

Med Ed 101

MARCH 31, 2024

The Kidney Disease: Improving Global Outcomes (KDIGO) organization has released an updated April 2024 clinical practice guideline for the evaluation and management of Chronic Kidney Disease (CKD). The new 2024 KDIGO guidelines include 6 chapters dedicated to the evaluation of CKD, risk assessment in people with CKD, management to delay CKD progression and manage its […] The post 2024 KDIGO Guidelines: The MOST Important Medication Recommendations appeared first on Med Ed 101.

94

94

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

The Guardian - Pharmaceutical Industry

MARCH 31, 2024

New tool may offer prescription ‘safety net’ and reduce the 237m medication errors made each year in England Drugs are a cornerstone of medicine, but sometimes doctors make mistakes when prescribing them and patients don’t take them properly. A new AI tool developed at Oxford University aims to tackle both those problems. DrugGPT offers a safety net for clinicians when they prescribe medicines and gives them information that may help their patients better understand why and how to take them.

84

84

The FDA Law Blog

MARCH 31, 2024

By Ana Loloei & Jeffrey N. Gibbs — On March 21, 2024, the House Energy and Commerce held a subcommittee hearing titled “Evaluating Approaches to Diagnostic Test Regulation and the Impact of the FDA’s Proposed Rule.” House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) and Subcommittee Chair Brett Guthrie (R-KY), in announcing the hearing, made their views clear: “FDA has proposed a rule that relies upon dubious and misguided legal, economic, and public health arguments and

FDA 64

FDA Hospitals 64